ProfileGDS4095 / 202466_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 88% 88% 86% 86% 86% 86% 87% 86% 87% 88% 86% 86% 85% 85% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep110.165788
GSM709769LY2 SRC1-siRNA tamoxifen treated rep310.341688
GSM709765LY2 SRC1-siRNA untreated rep39.8038786
GSM709771LY2 SRC1-siRNA untreated rep19.817386
GSM709772LY2 SRC1-siRNA untreated rep29.8694386
GSM709775LY2 SRC1-siRNA untreated rep49.9731586
GSM709764LY2 control-siRNA tamoxifen treated rep210.111587
GSM709766LY2 control-siRNA tamoxifen treated rep39.9201386
GSM709768LY2 control-siRNA tamoxifen treated rep110.084387
GSM709777LY2 control-siRNA tamoxifen treated rep410.198588
GSM709770LY2 control-siRNA untreated rep39.9747986
GSM709773LY2 control-siRNA untreated rep19.9109786
GSM709774LY2 control-siRNA untreated rep29.7662585
GSM709776LY2 control-siRNA untreated rep49.7751385